Questcor (QCOR) Under Pressure on Continue Reimbursement Worries
Tweet Send to a FriendGet Alerts QCOR Hot Sheet
Price: $37.21 -1.06%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
EPS Growth %: +24.6%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
EPS Growth %: +24.6%
Trade QCOR Now!
Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) sees pressure as traders pass around a Blue Cross/Blue Sheild of Michigan Drug Review showing the company's Acthar is only covered for infantile spasms.
Link
Shares of QCOR last traded at $27.80, down 7%.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Link
Shares of QCOR last traded at $27.80, down 7%.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- Canadian Solar (CSIQ) Continues Higher Following Arbitration Win Over LDK (LDK)
- Yahoo! (YHOO) Board Said to Approve $1.1B Tumblr Deal
Create E-mail Alert Related Categories
Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
